• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Blood Banking And Blood Products - Global Strategic Business Report Product Image

Blood Banking And Blood Products - Global Strategic Business Report

  • ID: 338362
  • October 2012
  • Region: Global
  • 1025 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 232 companies including leading blood banks such as AABB, Americas Blood Centers, American Red Cross, Canadian Blood Services, Japan Red Cross, National Blood Foundation, and New York Blood Center. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Gen-Probe, Inc., Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Novartis Vaccines READ MORE >

Note: Product cover images may vary from those shown

BLOOD BANKING AND BLOOD PRODUCTS

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Blood Components and Plasma Products I-3
Whole Blood & Cellular Components I-4
WBCs I-4
RBCs I-4
Platelets I-4
Plasma Fractions I-4
Fresh Frozen Plasma I-4
Albumin Fractions I-4
Factor VIII I-5
Factor IX and Factor IX Complex I-5
Fibrin/Thrombin I-5
Equipment, Blood Tests and Consumables I-5
Automated Analyzers for Blood Analysis I-5
Blood Tests I-5
Consumables I-6

II. Executive Summary

1. MARKET OVERVIEW II-1
Healthcare Scares Propel the Market II-1
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts II-1
Worldwide Blood Banking and Blood Products Market at a Glance
(All figures are 2012 estimates & CAGR is for the period
2010-2018) II-2
Current and Future Analysis II-2
Analysis by Geographic Region II-2
Analysis by Product Segment II-3
World Blood Components and Plasma Market Analysis in Units II-3
Table 1: World Recent Past, Current & Future Analysis for
Blood Components and Plasma by Region/Country - US, Europe,
Japan, and Rest of World Markets Independently Analyzed with
Annual Consumption in Million Units for Years 2010 through
2018 (includes corresponding Graph/Chart) II-4

Table 2: World 9-Year Perspective for Blood Components and
Plasma by Region/Country - Percentage Breakdown of Volume
Consumption for US, Europe, Japan, and Rest of World Markets
for Years 2010, 2012 & 2018 (includes corresponding
Graph/Chart) II-5
Red Blood Cells - A Key Blood Component and a Major Contributor II-6
Table 3: World Recent Past, Current & Future Analysis for Red
Blood Cells by Region/Country - US, Europe, Japan, and Rest
of World Markets Independently Analyzed with Annual
Consumption in Million Units for Years 2010 through 2018
(includes corresponding Graph/Chart) II-6

Table 4: World 9-Year Perspective for Red Blood Cells by
Region/Country - Percentage Breakdown of Volume Consumption
for US, Europe, Japan, and Rest of World Markets for Years
2010, 2012 & 2018 (includes corresponding Graph/Chart) II-7
Blood Plasma Derivatives: An Overview II-7
Blood Plasma Sourcing II-7
Plasma Derived Products: Production II-8
IVIG II-8
Factor VIII II-8
Albumin II-8
Costs Associated with Plasma Derivatives Production II-8
Table 5: Global Plasma Derivatives Market: Percentage
Breakdown of Costs Associated with Production (includes
corresponding Graph/Chart) II-9
Player Scenario II-9
Table 6: Global Plasma Derived Products Market (2011):
Percentage Share Breakdown by Leading Players - Baxter, CSL,
Grifols (incl. Talecris), Octapharma, LFB, Biotest, Kedrion
and Others (includes corresponding Graph/Chart) II-9

Table 7: Global IVIg Market (2011): Percentage Breakdown of
Market Share for Leading Players (includes corresponding
Graph/Chart) II-10
Indications Addressed by Major Global IVIg Manufacturers II-10
Table 8: Comparative Costs between Plasma Protein Therapies
and Artificially Synthesized Pharmaceuticals (includes
corresponding Graph/Chart) II-10

Table 9: Global Plasma Market in the Recent Past (2008):
Market Shares of CSL Behring and Talecris in Select Plasma
Product Markets in terms of Revenues (includes corresponding
Graph/Chart) II-11
Competitive Landscape across Blood Banking, Blood Derived
Products and Plasma Production II-11
Table 10: Leading Players in the Global Blood Screening
Market (2011) (includes corresponding Graph/Chart) II-11

Table 11: Global Blood Derivatives Production (2011):
Percentage Share Breakdown of Leading Players - Baxter, CSL,
Grifols (incl. Talecris), Octapharma, Novo Nordisk, Bayer,
Pfizer, Non-Profit Organizations, and Others (includes
corresponding Graph/Chart) II-12

Table 12: Global Blood Plasma Manufacturing Market (2011):
Percentage Share Breakdown by Leading Players - Baxter, CSL,
Grifols (incl. Talecris), Pfizer, Novo Nordisk and Others
(includes corresponding Graph/Chart) II-12
Withdrawal of Octapharma's IVIG Proves Advantageous to
Competitors II-12

2. MARKET TRENDS & ISSUES II-14
Key Trends in Blood Banking/Pre-Transfusion Diagnostics II-14
Demand Exceeds Supply: Self-Sufficiency is the New Mantra II-14
PrIME: An Innovative High-Yield Process to Address Supply Dearth II-14
Present State of Plasma Fractionating Industry II-14
Plasma Fractionation Industry Concentrated in Developed
Countries II-15
PrIME Tackles the Issue of Currently Unprocessable Plasma II-15
New Infections - A Continuous Threat II-15
Safety and Availability: The Core Issues II-16
Decontamination: A Viable Process II-16
New Processes for Safer Blood Supply II-16
Diagnostic Innovative Procedures Help Blood Conservation II-17
Autologous Transfusion Strapping up for High Growth II-17
Enzyme Converted Cells Set to Rule the Industry II-17
Blood Unavailability: Substitutes to the Rescue II-17
Transfusions: Hospitals Making Way for Others II-18
Computer Identification Helps Patients II-18
SARS: A Case of Mistaken Identity? II-18
Pooling: Economical HIV Testing II-18
Private Cord Blood Banking: Flying High Despite Opposition II-19
Automation of Blood Banking - Nearing the Efficiency Frontier? II-19
Automated Instrumentation Taking the Front Seat II-19
Table 13: World Market for Blood Bank Technology (2011):
Percentage Breakdown of Revenues by Segment - Manual Blood
Bag Systems, Automated Systems, Component Lab, Commercial
Plasma, Blood Salvage, and Pathogen Inactivation (includes
corresponding Graph/Chart) II-20
Plasma Market: Automation Making Inroads II-20
The RBC Market - Slow to Catch Up II-20
Automation of Testing - Yet to Mature II-20
Automation to Suffice Shortage Problems II-21
How Near to the Efficiency Frontier? II-21

3. PRODUCT OVERVIEW II-22
Blood Banking and Blood Products Industry II-22
Blood Components and Plasma Products II-22
Equipment, Blood Tests and Consumables II-22
Automated Analyzers for Blood Analysis II-22
Blood Tests II-22
Consumables II-23
Blood Collection Equipment II-23
Blood Collection Monitors II-23
Blood Donor Couches II-23
Blood Processing Equipment II-23
Blood Bank Centrifuges II-23
Plasma Thawing II-23
Blood Cell Separators II-24
Blood Storage Equipment II-24
Blood Bags II-24
Platelet Agitators II-24
Blood Bank Refrigerators II-24
Blood - A Primer II-24
Ionic Structure II-24
Blood Components and their Applications II-25
Blood Constituents II-26
Plasma II-26
Red Blood Cells (RBC) II-26
Blood Count II-27
Platelets II-27
White Blood Cells (WBC) II-27
Derivative Products of Blood or Plasma Fractions II-28
Plasma Protein and Fractionation II-28
Plasma Fractionation: Origins and Development II-28
Table 14: Plasma Fractionation Processes: Comparison of
Cohn IVIG and PrIME IVIG Based on Specific Characteristics II-29
The Need II-29
Fresh Frozen Plasma II-29
Other Plasma Fractions II-29
Albumin Fractions II-30
Albumin Usage Rising in Profile, Wastage Worries Run Deep II-30
Immunoglobulins II-30
Immunoglobulin Products Available in the Market (2012) II-30
Table 15: Leading Countries in IVIg Usage Rates in Grams per
1000 Population (includes corresponding Graph/Chart) II-31
Hyper-Immune Immunoglobulin II-31
Factor VIII II-31
Factor IX and Factor IX Complex II-31
Fibrin/Thrombin II-31
Consumption of Blood Based on Type of Surgery/Accident (In
Units) II-32
Table 16: World Market for Plasma Derivatives (2011):
Percentage Breakdown of Revenues by Product Type - IVIG,
Albumin, vWFactor & pdFVIII, Hyperimmunes, A1PI, Poly IG and
Others (includes corresponding Graph/Chart) II-32
Recombinant Products II-32
Development Pipeline of Select rFVIII Products for
Hemophilia A Therapy: Breakdown by Product Name, Developing
Company, State of Development and Expected Market Launch II-33
Table 17: Global Market for Recombinant Hemophilia Therapy
(2011): Percentage Share Breakdown for Leading Players
(includes corresponding Graph/Chart) II-33
Therapeutic Uses of Plasma Products II-33
Albumin Products II-33
Immunoglobulins II-34
Intravenous Immunoglobulin (IVIg) II-34
Normal Immunoglobulin (IMIg) II-34
CMV Immunoglobulin II-34
Hepatitis B Immunoglobulin II-34
Rh (D) Immunoglobulin II-34
Tetanus Immunoglobulin IM II-34
Zoster Immunoglobulin II-35
Table 18: Global Market for Immunoglobulins (IG) (2012):
Percentage Share Breakdown of Leading Products (includes
corresponding Graph/Chart) II-35
Plasma Derived Coagulant Products II-35
Biostate® II-35
Ceprotin® II-35
Factor VII Concentrate II-35
Factor XI Concentrates II-35
Feiba VH® Inhibitor Treatment II-36
Fibrogammin P® II-36
Monofix®-VF II-36
ProthrombinexTM-HT II-36
Thrombotrol®-VF II-36

4. BLOOD COLLECTION METHODS II-37
Banking the Natural Blood Resources II-37
Blood Banks II-37
Blood Banking II-37
Blood Transfusion II-37
Role of Blood Banks II-37
Blood Donor: The Epicenter of the Process II-37
Eligibility Criteria for the Donor II-38
The Basics of Blood Donation - Myths Exploded & Other Facts II-38
Table 19: Active Donors of Whole Blood and Apheresis per
1,000 of Population by Country/ Agency (includes
corresponding Graph/Chart) II-39

Table 20: Percentage Breakdown of Apheresis and Whole Blood
Donations by Country (includes corresponding Graph/Chart) II-39
Collection Methods II-40
Blood Donation: The Process II-40
Types of Blood Donation II-40
Directed Blood Donations II-40
Autologous Blood Donation II-40
Alternative Usage of Patient's Own Blood II-40
General Blood Donation II-40
Hemodilution II-41
Wound Drainage II-41
Cell Saver II-41
The Method II-41
Blood Salvaging II-41
Blood Collection Centers II-41
Blood Collection Management System II-42
A Historical Retrospective II-42
Blood Collection Centers II-42
Types of Blood Collection Centers II-42
Cord Blood Banks II-42
Profit Collection Centers II-42
Military Blood Banks II-43
Hospital Blood Banks II-43
Community Blood Banks II-43
Non-Profit Collection Centers II-43
Blood Processing II-43
Blood Typing II-44
Rh Blood Group System II-44
ABO Blood Group System II-45
Blood Types and their Compatibility II-45
Table 21: Occurrence of Blood Groups Worldwide (In %)
(includes corresponding Graph/Chart) II-45
Blood Test II-46
Blood Culture II-46
The Costs II-46
History of Blood Banking II-46

5. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS II-49
Blood Transfusion: A Backdrop II-49
Massive Transfusion II-49
Complications and Risks Due to Transfusion II-49
Circulatory Overload II-50
Graft Versus Host Disease (GVHD) II-50
Hemolytic Transfusion Reactions II-50
Iron Overload II-50
Bacterial Contamination II-50
Thrombophlebitis II-50
Allergic Reactions II-50
Air Embolism II-50
Hyperkalaemia II-51
Changing Role of Blood Banking Technology II-51

6. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES II-52
Cross Matching II-52
Blood Donor/Recipient Screening II-52
Blood Typing II-52
Leukoreduction II-52
Leukocyte Reduction Specification Standards/Filters II-53
Coombs Test II-53

7. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY II-54
Bloodless Surgery II-54
Therapeutic Apheresis II-54
Plasmapheresis II-54
Plateletpheresis II-54
Leukapheresis II-55
Volume Expanders II-55
Colloids II-55
Albumin II-55
Dextrans II-55
Hydroxyethyl Starch II-55
Crystalloids II-55
Blood Growth Factor Therapies - Newer Alternatives to Transfusion II-56

8. BLOOD SUBSTITUTES II-57
Blood Substitutes Under Development by Manufacturers II-57
Synthetic Blood Manufacturers/Developers II-58
Alliance Pharmaceuticals Corp. (US) II-58
Biopure Corporation (US) II-58
Enzon Pharmaceuticals (US) II-59
Hemosol Inc. (Canada) II-59
Northfield Laboratories Inc. (US) II-59
Synthetic Blood International, Inc. (US) II-59

9. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE
BUILDER II-60
Americas Blood Centers Launches Management System for Blood
Products II-60
Biomatrica Introduces DNAstable® Blood and DNAgard® Blood for
Whole Blood Stabilization at Room Temperature II-60
Bio-Rad Launches Fully-Automated IH 1000 Blood Screening System II-60
Fenwal Receives US FDA Clearance for Fenwal Amicus® Separator
System II-61
BD Unveils BD Microtainer® MAP Microtube II-61
Pall Releases Advanced Blood Filter II-62
CaridianBCT Rolls Out RBCX Protocol II-62
ITL Launches TEGO™ Animal Blood Collection Kit II-63
Fenwal to Launch Modified ALYX Kit II-63
QIAGEN Launches New QIAsafe DNA Blood Products II-63
Gambro Introduces New Prismaflex eXeed™ System II-64
AnaSpec Unveils ‘SensoLyte® Rh110 Plasmin Activity Assay Kit II-64
Typenex® Medical Rolls Out New Barcode Blood Band II-65
Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry
Analyzer System II-65
BD Diagnostics Launches BD BACTEC™ FX Blood Culture System II-65
Beckman Coulter Launches UniCel DxH 800 Coulter® Cellular
Analysis System II-66

10. PRODUCT APPROVALS II-67
Quotient Receives FDA Approval for ALBAcyte Reagent RBC Products II-67
EMIT Wins FDA Market Approval for Hypotherm X HX100 Device II-67
MedPro Blood Collection Safety Products Obtain CE Mark II-67
Huaren Pharmaceutical GI and PD Solutions Obtain SFDA Approval II-68
Cerus INTERCEPT Blood System Obtains Approval from Swissmedic II-68
Abbott Obtains BLA Clearance from FDA for ABBOTT PRISM Chagas
Test II-68
CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel®
Automated Blood Collection System II-69
FDA Grants 510(K) Clearance for Expanded Use of Haemonetics II-69
Fenwal Secures FDA Approval for New Platelet Additive Solution II-69
BD Diagnostics Bags FDA Approval for BD Vacutainer® Rapid
Serum Tube II-70
Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test II-70

11. PRODUCT APPROVALS IN THE RECENT PAST II-72
Cerus Receives CE Mark Approval for the INTERCEPT Blood System
for Platelets II-72
Haemonetics Wins FDA Approval for the ACP 215 System II-72
Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance II-72
Pall's eBDS Receives Green Signal from FDA II-73
CardioPAT™ Surgical Blood Salvage System II-73
PCS® 2 - Set to Enhance Plasma Quality II-73
Dade Behring's D-Dimer Assay Strapping up for Roll Out II-73

12. RECENT INDUSTRY ACTIVITY II-74
Hologic to Take Over Gen-Probe II-74
ProMetic Obtains New Purchase under Octapharma Agreement II-74
Grifols Takes Over Talecris II-74
IVD Acquisition Acquires Immucor II-75
Nordson Takes Over Value Plastics II-75
American Red Cross Takes Over RBC Collection Assets of HemaCare II-75
Terumo Acquires CaridianBCT II-76
Bioniche to Take Over Plasvacc II-76
Logic Management Consulting to Take Over Guiyang Dalin
Biologic Technologies II-76
Humanwell Healthcare Acquires Further Stake in Zhongyuan Ruide
Bio II-76
Red Cross and Mitsubishi Tanabe to Combine Plasma
Fractionation Business II-77
Fenwal Signs Definitive Agreement with Golden Meditech to Set
Up JV II-77
Fenwal and Biolog-id Enter into Marketing Agreement II-77
GE Healthcare and Neste Jacobs Enter into Partnership II-78
Cerus Enters into Supply Agreement with Etablissement Francais
du Sang II-78
Transfusion Management Services and Vedant Enter into Partnership II-78
Global Healing Collaborates with Partners in Health II-79
ProMetic Expands Strategic Partnership with WIBP II-79
Amunix Partners with Biogen Idec II-80
Fenwal and GenesisBPS Ink Agreement for Blood-Specialty Products II-80
Remi Enters into Collaboration with Barkey for Indian Market II-80
Huaren Pharma to Set Up R&D Center for Blood Purification II-80
China Biologic to Commence Commercial Collection of Plasma at
Ninyang II-81
Grifols to Construct Plasma Fractionation Plant II-81
HLL Lifecare Inaugurates Second Blood Bag Plant in India II-81

13. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-82
Pall Inks Distribution Agreement with ASI II-82
Cerus Inks Deal with Swiss Red Cross for Deploying INTERCEPT
Blood System II-82
PT Bio Farma to Construct New Albumin Plant in Indonesia II-82
NACO to Establish Plasma Fractionation Facility in Chennai II-82
Improve Medical Instruments to Establish Subsidiary in Beijing II-83
China Biologic Products Obtains License for Plasma Collection
from Shandong Province Health Department II-83
Sorin Group Sells Two Non-Core Product Lines to Cytomedix II-83
Sigma to Lease QC Manager Software to New Orleans based Blood
Center II-83
CaridianBCTs PRT System Chosen by Polish Health Ministry II-84
Micronics Obtains FDA Approval to Market ABORhCard II-84
HemaCare Signs Two New Blood Service Contracts II-84
Haemonetics Gains Rights to Alba's Full Line of Blood Typing
Reagents II-85
American Red Cross Inks 3-Year Deal with ITL II-85
Daxor's Idant Labs Bags Blood Banking Contract from RMSB&G II-85
Beckman Coulter Agrees to Distribute CellaVision Digital
Morphology Products II-86
Haemonetics Takes Over Global Med II-86
Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments II-86
MRHC Obtains License for SafeTrace Tx Solution of Global Med II-87
Life Technologies to Acquire AcroMetrix II-87
Heska Enters into a Supply Agreement with Roche Diagnostics II-87
BLOOD Bank of Alaska Obtains License for Mediware's LifeTrak
Technology II-88
Europe and the US Expand Blood Banking Agreement II-88
Pfizer Acquires Wyeth II-89
Baxter Inaugurates New BLOOD Plasma Fractionation Facility in
Vienna II-89
ProMetic Acquires Majority Shareholding in PRDT II-89
China Biologic to Collaborate with IBT on Research & Development II-90
Gen-Probe to Establish Independent New Firm for Industrial
Testing II-90
Haemonetics Acquires SEBRA Blood Collection & Processing Unit II-91
Beckman Coulter Acquires Lab Based Diagnostics Business of
Olympus II-92
Golden Meditech and Fenwal to Establish a Blood Collection
Joint Venture in China II-92
PRCS Inaugurates State-of-the-Art Blood Bank II-92
CSL and Talecris Terminate Merger Agreement II-93
Immucor Inks 5-Year Deal with Alverno II-93
Gen-Probe Acquires Tepnel and Renews Partnership with Novartis II-94
Haemonetics Takes Over Neoteric Technology II-94
Haemonetics Acquires Altivation Software II-95
PacifiCord Sets Up Cord Blood Banking Facility in Irvine II-95
China Biologic Acquires 35% Stake in Xi`an Huitian Blood Products II-95
Octapharma Plans to Set Up Fractionation Facility in Poland II-96
Therapure BioPharma Inks Development Services Deal with LFB
Biotechnologies II-96
Biotest Acquires Blood Plasma Collection Center from Talecris II-96
Gen-Probe Expands and Extends Blood Screening Alliance with
Novartis II-96
Celestial Biologicals Collaborates with GE Healthcare for
Indian Market II-97

14. FOCUS ON SELECT GLOBAL PLAYERS II-98
Leading Blood Banks II-98
AABB (US) II-98
America's Blood Centers (US) II-98
American Red Cross (US) II-98
Canadian Blood Services (Canada) II-99
Japan Red Cross Society (Japan) II-99
National Blood Foundation (US) II-99
New York Blood Center (US) II-100
Leading Players in Blood Bank Technology and Supplies II-100
Beckman Coulter, Inc. (US) II-100
Becton, Dickinson and Company (US) II-100
BioMerieux SA (France) II-101
CSL Behring LLC (US) II-101
Daxor Corporation (US) II-101
Fenwal Inc. (US) II-102
Gen-Probe, Inc. (US) II-102
Haemonetics Corporation (US) II-102
Hemagen Diagnostics Inc. (US) II-103
Immucor Inc. (US) II-103
Kawasumi Laboratories, Inc. (Japan) II-104
Novartis Vaccines and Diagnostics, Inc (US) II-104
Terumo Corp. (Japan) II-105
Terumo BCT Inc (US) II-105
ThermoGenesis Corp. (US) II-105
Velico Medical, Inc. (US) II-106
Leading Players in Plasma Fractionation II-106
Baxter International Inc. (US) II-106
Beijing Tiantan Biological Products Co., Ltd (China) II-106
Bharat Serums and Vaccines Ltd (India) II-106
Bio Products Laboratory Ltd (UK) II-107
Biotest AG (Germany) II-107
CSL Limited (Australia) II-107
Grifols, S.A (Spain) II-108
Guizhou Taibang Biological Products Co., Ltd (China) II-108
Huanlan Biological Engineering Inc. (China) II-109
Kedrion S.p.A. (Italy) II-109
Laboratoire Français du Fractionnement et des Biotechnologies
(France) II-109
Octapharma AG (Switzerland) II-109
OMRIX Biopharmaceuticals Ltd (Israel) II-110
Shanghai RAAS Blood Products Co., Ltd. (China) II-110
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd (China) II-110
Sanquin (The Netherlands) II-110

15. GLOBAL MARKET PERSPECTIVE II-111
Table 22: World Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) II-111

Table 23: World Historic Review for Blood Banking and Blood
Products by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-112

Table 24: World 15-Year Perspective for Blood Banking and
Blood Products by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-113
Blood Banking and Blood Products Market by Product Group/Segment II-114
Table 25: World Recent Past, Current & Future Analysis for
Blood Components and Plasma Products by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) II-114

Table 26: World Historic Review for Blood Components and
Plasma Products by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-115

Table 27: World 15-Year Perspective for Blood Components and
Plasma Products by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-116

Table 28: World Recent Past, Current & Future Analysis for
Blood Components and Plasma Products by Product Segment -
Whole Blood & Cellular Components, and Plasma Fractions
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-117

Table 29: World Historic Review for Blood Components and
Plasma Products by Product Segment - Whole Blood & Cellular
Components, and Plasma Fractions Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) II-118

Table 30: World 15-Year Perspective for Blood Components and
Plasma Products by Product Segment - Percentage Breakdown of
Value Sales for Whole Blood & Cellular Components, and Plasma
Fractions Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) II-119

Table 31: World Recent Past, Current & Future Analysis for
Whole Blood & Cellular Components by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) II-120

Table 32: World Historic Review for Whole Blood & Cellular
Components by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-121

Table 33: World 15-Year Perspective for Whole Blood & Cellular
Components by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) II-122

Table 34: World Recent Past, Current & Future Analysis for
Plasma Fractions by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-123

Table 35: World Historic Review for Plasma Fractions by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-124

Table 36: World 15-Year Perspective for Plasma Fractions by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2004, 2011 &
2018 (includes corresponding Graph/Chart) II-125

Table 37: World Recent Past, Current & Future Analysis for
Equipment, Blood Tests and Other Consumables by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-126

Table 38: World Historic Review for Equipment, Blood Tests and
Other Consumables by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-127

Table 39: World 15-Year Perspective for Equipment, Blood Tests
and Other Consumables by Geographic Region - Percentage
Breakdown of Value Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) (includes corresponding
Graph/Chart) II-128

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Table 40: Blood and Organ Banks in the US (2011):
Percentage Share Breakdown of Revenues for Major Players -
American Red Cross, Musculoskeletal Transplant Foundation
Inc., Community Blood Center and Community Tissue Services
and CSL Ltd. (includes corresponding Graph/Chart) III-1

Table 41: US Blood Bank Industry (2011): Percentage Share
Breakdown by Major Blood Suppliers (includes corresponding
Graph/Chart) III-2
Market Trends III-2
Recession Impacts Blood Bank Reserves III-2
US Blood Collection & Supply Profile III-2
Blood Group Distribution III-3
Table 42: US Market for Blood Banking and Blood Products:
Percentage Break up of Blood Group by Rh Factor (includes
corresponding Graph/Chart) III-3

Table 43: Percentage Break up of Rh Blood Types in the US
by Racial Group (includes corresponding Graph/Chart) III-4
Blood Donated and Transfused Every Year III-4
Males Form the Major Chunk of Donors III-4
Cost of Blood III-4
SARS Scares: Blood Banks Feel the Heat III-4
Blood and Blood Preparations: A Review of Trade Statistics III-5
Table 44: US Blood and Blood Preparations Market (2010 &
2011): Percentage Breakdown of Value Imports by Country of
Origin for Germany, UK, Canada, Switzerland, Belgium and
Others (includes corresponding Graph/Chart) III-5

Table 45: US Blood and Blood Preparations Market (2010 &
2011): Percentage Breakdown of Value Exports by Destination
for UK, Germany, Canada, Netherlands, Belgium and Others
(includes corresponding Graph/Chart) III-6

Table 46: US Market for Globulins (2011): Percentage
Breakdown by Leading Players for Baxter, Grifols (incl.
Talecris), CSL and Octapharma (includes corresponding
Graph/Chart) III-6
US Blood Components and Plasma Market Analysis in Units III-7
Table 47: US Recent Past, Current & Future Analysis for
Blood Components and Plasma by Product Category - Red Blood
Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets
Independently Analyzed with Annual Consumption in Million
Units for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-7

Table 48: US Historic Review for Blood Components and
Plasma by Product Category - Red Blood Cells (RBCs),
Platelets, and Fresh Frozen Plasma Markets Independently
Analyzed with Annual Consumption in Million Units for Years
2004 through 2009 (includes corresponding Graph/Chart) III-8

Table 49: US 15-Year Perspective for Blood Components and
Plasma by Product Category - Percentage Breakdown of Volume
Consumption for Red Blood Cells (RBCs), Platelets, and
Fresh Frozen Plasma for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-8
Regulations Control Plasma Collection Industry III-9
Product launch III-9
Strategic Corporate Developments III-9
Key players III-13
B.Market Analytics III-21
Table 50: US Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-21

Table 51: US Historic Review for Blood Banking and Blood
Products by Product Group/ Segment - Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-22

Table 52: US 15-Year Perspective for Blood Banking and Blood
Products by Product Group/ Segment - Percentage Breakdown of
Value Sales for Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets for
Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) III-23

2. CANADA III-24
A.Market Analysis III-24
Current and Future Analysis III-24
Blood Facts III-24
Bleeding Disorders - A Major Threat III-24
CSA-Z902-04 - A Comprehensive Voluntary Blood Safety Standard III-24
Blood and Blood Preparations: Import & Export Scenario III-25
Table 53: Canadian Blood and Blood Preparations Market
(2010 & 2011): Percentage Breakdown of Value Imports by
Country of Origin for US, Switzerland, Germany,
Netherlands, UK and Other Countries (includes corresponding
Graph/Chart) III-25

Table 54: Canadian Blood and Blood Preparations Market
(2010 & 2011): Percentage Breakdown of Value Exports by
Destination for US, France, UK, Japan, Australia and Other
Countries (includes corresponding Graph/Chart) III-26
Strategic Corporate Development III-26
Canadian Blood Services - the Major Blood Bank III-27
B.Market Analytics III-28
Table 55: Canadian Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-28

Table 56: Canadian Historic Review for Blood Banking and
Blood Products by Product Group/ Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-29

Table 57: Canadian 15-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-30

3. JAPAN III-31
A.Market Analysis III-31
Current and Future Analysis III-31
Japan Witnesses Surge in Imported Blood Products III-31
Growing Market for Fresh Frozen Plasma III-31
Growing Use of Imported Albumin Based Blood Products III-31
The Goal of Self-Sufficiency III-32
Strategic Corporate Development III-33
Key players III-33
B.Market Analytics III-35
Table 58: Japanese Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-35

Table 59: Japanese Historic Review for Blood Banking and
Blood Products by Product Group/ Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-36

Table 60: Japanese 15-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-37

4. EUROPE III-38
A.Market Analysis III-38
Current and Future Analysis III-38
European Blood Banking and Blood Products Market at a
Glance (All figures are 2012 estimates & CAGR is for the
period 2010-2018) III-38
Market Trends and Issues III-39
Legislations on Payment for Donation Restrict Donors III-39
Government's Check on Healthcare Costs Pressurizes BCT
Manufacturers III-39
Purchasing System Witnesses Modifications III-39
EU Nations Marching Towards Self-Sufficiency in Blood and
Blood Products III-39
Blood Banking Devices Market III-39
Table 61: European Recent Past, Current & Future Analysis
for Blood Banking Devices - Manual Blood Collection,
Apheresis, and Autologous Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-40

Table 62: European Historic Review for Blood Banking
Devices - Manual Blood Collection, Apheresis, and
Autologous Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-41

Table 63: European 15-Year Perspective for Blood Banking
Devices - Percentage Breakdown of Value Sales for Manual
Blood Collection, Apheresis, and Autologous Markets for
Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-42

Table 64: European Blood Banking Devices Market (2012):
Percentage Breakdown of Value Sales by Geographic Region
for France, Germany, Italy, UK, Spain and Rest of Europe
(includes corresponding Graph/Chart) III-42
A Snapshot of Health Care Systems Across Select EU Countries III-43
France III-43
Germany III-43
Italy III-43
The UK III-43
Spain III-43
B.Market Analytics III-44
Table 65: European Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Geographic Region -
France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-44

Table 66: European Historic Review for Blood Banking and
Blood Products by Geographic Region - France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-45

Table 67: European 15-Year Perspective for Blood Banking and
Blood Products by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2004, 2011 & 2018
(includes corresponding Graph/Chart) III-46

Table 68: European Recent Past, Current & Future Analysis
for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-47

Table 69: European Historic Review for Blood Banking and
Blood Products by Product Group/Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-48

Table 70: European 15-Year Perspective for Blood Banking and
Blood Products by Product Group/ Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-49

4a. FRANCE III-50
A.Market Analysis III-50
Current and Future Analysis III-50
Strategic Corporate Development III-50
Key players III-50
B.Market Analytics III-52
Table 71: French Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-52

Table 72: French Historic Review for Blood Banking and Blood
Products by Product Group/Segment - Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-53

Table 73: French 15-Year Perspective for Blood Banking and
Blood Products by Product Group/ Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-54

4b. GERMANY III-55
A.Market Analysis III-55
Current and Future Analysis III-55
Biotest AG - A Key Player III-55
B.Market Analytics III-56
Table 74: German Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-56

Table 75: German Historic Review for Blood Banking and Blood
Products by Product Group/ Segment - Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-57

Table 76: German 15-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-58

4c. ITALY III-59
A.Market Analysis III-59
Current and Future Analysis III-59
Kedrion S.p.A. - A Key Player III-59
B.Market Analytics III-60
Table 77: Italian Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-60

Table 78: Italian Historic Review for Blood Banking and
Blood Products by Product Group/Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-61

Table 79: Italian 15-Year Perspective for Blood Banking and
Blood Products by Product Group/ Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-62

4d. THE UNITED KINGDOM III-63
A.Market Analysis III-63
Current and Future Analysis III-63
Blood Requirements III-63
Bio Products Laboratory Ltd - A Key Player III-63
B.Market Analytics III-64
Table 80: The UK Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-64

Table 81: The UK Historic Review for Blood Banking and Blood
Products by Product Group/Segment - Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-65

Table 82: The UK 15-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-66

4e. SPAIN III-67
A.Market Analysis III-67
Current and Future Analysis III-67
Strategic Corporate Development III-67
Grifols, S.A - A Key Player III-67
B.Market Analytics III-68
Table 83: Spanish Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-68

Table 84: Spanish Historic Review for Blood Banking and
Blood Products by Product Group/ Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-69

Table 85: Spanish 15-Year Perspective for Blood Banking and
Blood Products by Product Group/Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-70

4f. RUSSIA III-71
A.Market Analysis III-71
Current and Future Analysis III-71
B.Market Analytics III-72
Table 86: Russian Recent Past, Current & Future Analysis for
Blood Banking and Blood Products by Product Group/Segment -
Blood Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-72

Table 87: Russian Historic Review for Blood Banking and
Blood Products by Product Group/Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-73

Table 88: Russian 15-Year Perspective for Blood Banking and
Blood Products by Product Group/ Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-74

4g. REST OF EUROPE III-75
A.Market Analysis III-75
Current and Future Analysis III-75
Denmark - High Participation and Consumption of Blood III-75
Key players III-75
B.Market Analytics III-76
Table 89: Rest of Europe Recent Past, Current & Future
Analysis for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-76

Table 90: Rest of Europe Historic Review for Blood Banking
and Blood Products by Product Group/Segment - Blood
Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-77

Table 91: Rest of Europe 15-Year Perspective for Blood
Banking and Blood Products by Product Group/Segment -
Percentage Breakdown of Value Sales for Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-78

5. ASIA-PACIFIC III-79
A.Market Analysis III-79
Current and Future Analysis III-79
Overview of Select Regional Markets III-79
ASEAN - Striding Towards Standardization of Blood Supply III-79
China - A Key Market III-79
Blood Collection Industry: A Snapshot of the Past III-79
Blood Products Industry - An Overview III-80
Performance Review III-80
Chinese Blood Products Industry Poised for Expansion III-81
Table 92: Blood Products Industry in China (2009 & 2011):
Percentage Breakdown by Product Type for Albumin, IVIG,
Coagulation Factor and Others (includes corresponding
Graph/Chart) III-81
Volume Declines but Revenues Shoot Up in Chinese Blood
Products Market III-81
Government Wakes Up to Realities III-82
Table 93: Chinese Market for Blood Banking and Blood
Products: Percentage Breakdown of Blood Group by Type -
A, B, O, and AB (includes corresponding Graph/Chart) III-82

Table 94: Chinese Market for Blood Banking and Blood
Products: Percentage Breakdown of Blood Donor by Gender -
Male and Female (includes corresponding Graph/Chart) III-82

Table 95: Chinese Blood Banking and Blood Products
Market: Percentage Breakdown of Blood Donor by Age Group -
16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes
corresponding Graph/Chart) III-83
Albumin Market in China Gains Favor of both Global and
Local Players III-83
Table 96: Albumin Market in China (2011): Percentage
Share Breakdown by Leading Players - CSL, Octapharma,
Baxter, Grifols, CBPO, Hualan Biological, Chengdu
Rongsheng, Sichuan Yuanda, Green Cross and Others
(includes corresponding Graph/Chart) III-83
India III-84
Blood Banking Equipment Market on the Rise III-84
Tube Sealers and Blood Bags Dominate the Market III-84
Recent Trends in the Market III-84
Indian Blood Banking Market Witnesses Major Transformations III-85
Market Growth - Influencing Factors III-85
Increased Awareness Drives Voluntary Blood Donations in India III-85
Competitive Scenario III-86
Australia III-87
National Blood Supply: An Overview III-87
Role of National Blood Authority III-87
Maintenance Expenditure on the Rise III-87
Indonesia III-87
Strategic Corporate Developments III-88
Key players III-90
B.Market Analytics III-93
Table 97: Asia-Pacific Recent Past, Current & Future
Analysis for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-93

Table 98: Asia-Pacific Historic Review for Blood Banking and
Blood Products by Product Group/ Segment - Blood Components
and Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-94

Table 99: Asia-Pacific 15-Year Perspective for Blood Banking
and Blood Products by Product Group/ Segment - Percentage
Breakdown of Value Sales for Blood Components and Plasma
Products (Whole Blood & Cellular Components, and Plasma
Fractions)
and Equipment, Blood Tests and Other Consumables
Markets for Years 2004, 2011 & 2018 (includes corresponding
Graph/Chart) III-95

6. LATIN AMERICA III-96
A.Market Analysis III-96
Current and Future Analysis III-96
Strategic Corporate Development III-96
B.Market Analytics III-97
Table 100: Latin American Recent Past, Current & Future
Analysis for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-97

Table 101: Latin American Historic Review for Blood Banking
and Blood Products by Product Group/ Segment - Blood
Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-98

Table 102: Latin American 15-Year Perspective for Blood
Banking and Blood Products by Product Group/Segment -
Percentage Breakdown of Value Sales for Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-99

7. REST OF WORLD III-100
A.Market Analysis III-100
Current and Future Analysis III-100
OMRIX Biopharmaceuticals Ltd (Israel) - A Key player III-100
B.Market Analytics III-101
Table 103: Rest of World Recent Past, Current & Future
Analysis for Blood Banking and Blood Products by Product
Group/Segment - Blood Components and Plasma Products (Whole
Blood & Cellular Components, and Plasma Fractions)
and
Equipment, Blood Tests and Other Consumables Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-101

Table 104: Rest of World Historic Review for Blood Banking
and Blood Products by Product Group/ Segment - Blood
Components and Plasma Products (Whole Blood & Cellular
Components, and Plasma Fractions)
and Equipment, Blood
Tests and Other Consumables Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-102

Table 105: Rest of World 15-Year Perspective for Blood
Banking and Blood Products by Product Group/Segment -
Percentage Breakdown of Value Sales for Blood Components and
Plasma Products (Whole Blood & Cellular Components, and
Plasma Fractions)
and Equipment, Blood Tests and Other
Consumables Markets for Years 2004, 2011 & 2018 (includes
corresponding Graph/Chart) III-103

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 228 (including Divisions/Subsidiaries - 331)

The United States (141)
Canada (15)
Japan (11)
Europe (102)
- France (11)
- Germany (25)
- The United Kingdom (17)
- Italy (6)
- Spain (4)
- Rest of Europe (39)
Asia-Pacific (Excluding Japan) (49)
Latin America (7)
Africa (4)
Middle East (2)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos